Literature DB >> 28779447

Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?

Francesco Dentali1, Silvia Galliazzo2, Francesca Zuretti2, Monica Gianni3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28779447     DOI： 10.1007/s11739-017-1725-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  17 in total

1.  The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.

Authors:  Vaibhav Keskar; Eric McArthur; Ron Wald; Ziv Harel; Deborah Zimmerman; Amber O Molnar; Amit X Garg; Ngan N Lam; Megan K McCallum; Sarah E Bota; Jeffrey Perl; Manish M Sood
Journal:  Kidney Int       Date:  2016-12-22       Impact factor: 10.612

2.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

3.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

4.  A prospective validation of the SAME-TT2R 2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin.

Authors:  Daniela Poli; Emilia Antonucci; Sophie Testa; Gregory Yoke Hong Lip
Journal:  Intern Emerg Med       Date:  2014-03-21       Impact factor: 3.397

Review 5.  Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.

Authors:  Nick van Es; Michiel Coppens; Sam Schulman; Saskia Middeldorp; Harry R Büller
Journal:  Blood       Date:  2014-06-24       Impact factor: 22.113

6.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

7.  An update on the pharmaceutical management of thrombosis.

Authors:  Benilde Cosmi
Journal:  Expert Opin Pharmacother       Date:  2016-10-12       Impact factor: 3.889

8.  Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago.

Authors:  Gualtiero Palareti; Emilia Antonucci; Ludovica Migliaccio; Nicoletta Erba; Francesco Marongiu; Vittorio Pengo; Daniela Poli; Sophie Testa; Alberto Tosetto; Armando Tripodi; Marco Moia
Journal:  Intern Emerg Med       Date:  2017-05-13       Impact factor: 3.397

9.  Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.

Authors:  Laila Staerk; Emil Loldrup Fosbøl; Gregory Y H Lip; Morten Lamberts; Anders Nissen Bonde; Christian Torp-Pedersen; Brice Ozenne; Thomas Alexander Gerds; Gunnar Hilmar Gislason; Jonas Bjerring Olesen
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

10.  Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.

Authors:  Torben Bjerregaard Larsen; Flemming Skjøth; Peter Brønnum Nielsen; Jette Nordstrøm Kjældgaard; Gregory Y H Lip
Journal:  BMJ       Date:  2016-06-16
View more
  1 in total

1.  Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists.

Authors:  Alessandro Cipriano; Alessio Pecori; Alessandra Eugenia Bionda; Michele Bardini; Francesca Frassi; Francesco Leoli; Valentina Lami; Lorenzo Ghiadoni; Massimo Santini
Journal:  Intern Emerg Med       Date:  2018-03-08       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.